Serum matrix metalloproteinase-3 (MMP-3) as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.

被引：0
|
作者：
Shinozaki, Mikiko [1 ]
Inoue, Eisuke [1 ]
Iikuni, Noriko [1 ]
Hara, Masako [1 ]
Tomatsu, Taisuke [1 ]
Kamatani, Naoyuki [1 ]
Yamanaka, Hisashi [1 ]
机构：
[1] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [21] Relationship of the clinical efficiency of tocilizumab therapy to the serum level of matrix metalloproteinase-3 in patients with rheumatoid arthritis
    Avdeeva, A. S.
    Aleksandrova, E. N.
    Novikov, A. A.
    Cherkasova, M. V.
    Panasyuk, E. Yu.
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (05) : 24 - 29
  • [22] Serum levels of matrix metalloproteinase-3 in rheumatoid arthritis (RA) follow-up.
    Pozzi, MR
    Banfi, E
    Redaelli, C
    Montani, N
    Mariani, E
    D'Angelo, L
    Stabilini, R
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S184 - S184
  • [23] Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients
    Galil, Sahar Mahfouz Abdel
    El-Shafey, Abeer Mohamed
    Hagrass, Hoda A.
    Fawzy, Faten
    El Sammak, Ahmed
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (04) : 377 - 384
  • [24] Serum and synovial matrix metalloproteinase-3 as markers of disease activity in early rheumatoid arthritis
    Rasha Mohamed Fawzy
    Yasser A. Abdel Hamid
    Mona M. Albehesy
    Rasha F. Aboelmaged
    Egyptian Rheumatology and Rehabilitation, 2016, 43 (4) : 178 - 183
  • [25] Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up
    Mark Houseman
    Catherine Potter
    Nicola Marshall
    Rachel Lakey
    Tim Cawston
    Ian Griffiths
    Steven Young-Min
    John D Isaacs
    Arthritis Research & Therapy, 14
  • [26] Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up
    Houseman, Mark
    Potter, Catherine
    Marshall, Nicola
    Lakey, Rachel
    Cawston, Tim
    Griffiths, Ian
    Young-Min, Steven
    Isaacs, John D.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (01)
  • [27] Continuously elevated serum matrix metalloproteinase-3 for 3 ∼ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study
    Ma, Jian-Da
    Wei, Xiu-Ning
    Zheng, Dong-Hui
    Mo, Ying-Qian
    Chen, Le-Feng
    Zhang, Xiang
    Li, Jing-Hua
    Dai, Lie
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [28] Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study
    Jian-Da Ma
    Xiu-Ning Wei
    Dong-Hui Zheng
    Ying-Qian Mo
    Le-Feng Chen
    Xiang Zhang
    Jin-Hua Li
    Lie Dai
    Arthritis Research & Therapy, 17
  • [29] Elevated Serum MMP-3 in Remission Predicts Relapse in Patients with Rheumatoid Arthritis
    Chen, Le-Feng
    Ma, Jian-Da
    Wang, Jun-Wei
    Xu, Yan-Hui
    Yang, Kui-Min
    Lin, Jian-Zi
    Dai, Lie
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] The Serum Matrix Metalloproteinase-3 Level and The 5A/6A Single Nucleotide Polymorphism of MMP-3 in Patients With Acute Coronary Syndromes
    Zhang, Ji
    Wei, Yidong
    Xu, Yawei
    CIRCULATION, 2010, 122 (02) : E47 - E47
12345